Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 104394
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.104394
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.104394
Table 1 Definitions of some specific terms, n (%)
Clinical indicators | MSI (n = 28) | MSS (n = 28) | P value |
Gender | 1.000 | ||
Male | 15 (53.57) | 15 (53.57) | |
Female | 13 (46.43) | 13 (46.43) | |
Age, years | 67.39 ± 12.470 | 63.75 ± 11.407 | 0.259 |
Tumor size | 0.010 | ||
≥ 5 cm | 18 (64.29) | 6 (21.43) | |
< 5 cm | 10 (35.71) | 22 (78.57) | |
Lymph node metastases | 0.008 | ||
Degree of differentiation | 0.412 | ||
Stage | 0.019 | ||
≤ stage II | 21 (75.00) | 6 (21.43) | |
> stage II | 7 (25.00) | 22 (78.57) |
- Citation: Zuo H, Yuan Z, Gu MH, Xu W, Zhou JH, Zhang Y, Gu XH. Nutritional and inflammatory indicators differ among patients with colorectal cancer with distinct microsatellite stability statuses. World J Gastrointest Surg 2025; 17(5): 104394
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/104394.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.104394